Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1187-1194

  Peters, Christian ^a,b   Paterson, Yvonne ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CSL Behring   (United States)

Author keywords

Antigen loss; Listeria monocytogenes; Recombinant vaccine; Virulence

Indexed keywords

ANTIGEN; BACTERIAL VACCINE; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOENGINEERING; CLONING; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; IN VIVO STUDY; LISTERIA MONOCYTOGENES; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AIDS VACCINES; ANIMALS; ANTIGENS, VIRAL; BACTERIAL VACCINES; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION, BACTERIAL; GENE PRODUCTS, GAG; GENES, GAG; HIV ANTIGENS; HIV-1; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; SERIAL PASSAGE; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRULENCE;

EID: 0037424109     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00554-6     Document Type: Article

References (29)

1. Mackaness G. Cellular resistance to infection. J. Exp. Med. 116:1962;381-406.
2. Portnoy D.A., Chakraborty T., Goebel W., Cossart P. Molecular determinants of Listeria monocytogenes pathogenesis. Infect. Immun. 60:1992;1263-1267.
3. Schafer R., Portnoy D.A., Brassell S.A., Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol. 149:1992;53-59.
4. Ikonomidis G., Paterson Y., Kos F., Portnoy D. Delivery of a viral antigen to the class I processing and presentation pathway by L. monocytogenes. J. Exp. Med. 180:1994;2209-2218.
5. Ikonomidis G., Portnoy D.A., Gerhard W., Paterson Y. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. Vaccines. 15:1997;433-440.
6. + T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int. Immunol. 7:1995;797-805.
7. Pan Z.-K., Ikonomidis G., Lazenby A., Pardoll D., Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour challenge and causes regression of established tumours. Nat. Med. 1:1995;471-477.
8. Shen H., Slifka M.K., Matloubian M., Jensen E.R., Ahmed R., Miller J.F. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3987-3991.
9. Pan Z.K., Weiskirch L.M., Paterson Y. Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine. Cancer Res. 59:1999;5264-5269.
10. Mata M., Paterson Y. Th1 T cell responses to HIV-1 Gag protein delivered by an L. monocytogenes vaccine are similar to those induced by endogenous listerial antigens. J. Immunol. 163:1999;1449-1456.
11. Mata M., Yao Z., Zubair A., Syres K., Paterson Y. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge. Vaccine. 19:2001;1435-1445.
12. Gunn G.R., Zubair A., Peters C.H., Pan Z.-K., Wu T.-C., Paterson Y. Two L. monocytogenes vaccine vectors that express different molecular forms of HPV-16 E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J. Immunol. 167:2001;6471-6479.
13. Weiskirch L.M., Paterson Y. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease. Immunol. Rev. 158:1997;159-169.
14. Jensen E.R., Selvakumar R., Shen H., Ahmed R., Wettstein F.O., Miller J.F. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA. J. Virol. 71:1997;8467-8474.
15. Moors M.A., Levitt B., Youngman P., Portnoy D.A. Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes. Infect. Immun. 67:1999;131-139.
16. Ripio M.T., Dominguez-Bernal G., Suarez M., Brehm K., Berche P., Vazquez-Boland J.A. Transcriptional activation of virulence genes in wild-type strains of Listeria monocytogenes in response to a change in the extracellular medium composition. Res. Microbiol. 147:1996;371-384.
17. Berche P., Gaillard J., Sansonetti P.J. Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J. Immunol. 138:1987;2266-2271.
18. Mitsuyama M., Igarashi K., Kawamura I., Ohmori T., Nomoto K. Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes. Infect. Immun. 58:1990;1254-1260.
19. Camilli A., Goldfine H., Portnoy D.A. Listeria monocytogenes mutants lacking phosphatidylinositol-specific phospholipase C are avirulent. J. Exp. Med. 173:1991;751-754.
20. Berche P., Gaillard J.L., Richard S. Invasiveness and intracellular growth of Listeria monocytogenes. Infection. 16(S):1988;145-148.
21. Vahidy R., Waseem M., Khalid S.M. A comparative study of unpassaged and animal passaged cultures of Listeria monocytogenes in rabbits. Ann. Acad. Med. Singapore. 25:1996;139-553.
22. Mata M., Travers P.J., Liu Q., Frankel F.R., Paterson Y. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. J. Immunol. 161:1998;2985-2993.
23. Pamer E.G., Harty J.T., Bevan M.J. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature. 353:1991;852-855.
24. Renzoni A., Cossart P., Dramsi S. PrfA, the transcriptional activator of virulence genes, is upregulated during interaction of Listeria monocytogenes with mammalian cells and in eukaryotic cell extracts. Mol. Microbiol. 34:1999;552-561.
25. Waseem M., Vahidy R., Khan M.A. Correlation between production of listeriolysin O by variants of Listeria monocytogenes and their virulence for rabbits. Zentralbl Bakteriol. 282:1995;384-388.
26. North R.J., Berche P.A., Newborg M.F. Immunologic consequences of antibiotic-induced abridgement of bacterial infection: effect on generation and loss of protective T cells and level of immunologic memory. J. Immunol. 127:1981;342-346.
27. Tanabe Y., Xiong H., Nomura T., Arakawa M., Mitsuyama M. Induction of protective T cells against Listeria monocytogenes in mice by immunization with a listeriolysin O-negative avirulent strain of bacteria and liposome-encapsulated listeriolysin O. Infect. Immun. 67:1999;568-575.
28. Marshall N.E., Ziegler H.K. Role of bacterial hemolysin production in induction of macrophage Ia expression during infection with Listeria monocytogenes. J. Immunol. 147:1991;2324-2332.
29. de Chastellier C., Berche P. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect. Immun. 62:1994;543-553.